Loading...

BSX BOSTON SCIENTIFIC CORP Capital Structure Changes 8-K Filing

BSTN

BSX

BOSTON SCIENTIFIC CORP

(BSX)

2025 8-K

Show Summary

Show Summary

Product Discontinuation

Financial Statements

Senior Notes Offering

Board Departure

Financial Results

Court Settlement

Executive Compensation

Acquisition Completed

Clinical Trial Resumption

Q3 Financial Results

Appointment of Director

Earnings Reports

Appointment of Director and...

By-Laws Amendment

Financial Results Announcement

Underwriting Agreement for ...

Appointment of Officers

Financial Results Announcement

Merger Agreement

Acquisition of Axonics, Inc.

Departure of Directors and ...

Earnings Reports

Earnings Reports

Appointment of Directors

Conversion of Preferred Stock

Annual Meeting of Stockholders

Financial Results Announcement

External Links:

On February 21, 2025, Boston Scientific entered into an Underwriting Agreement for the issuance of $1.5 billion in senior notes, with $1.487 billion net proceeds expected to be used for debt repayment and corporate purposes.

AI Assistant

BOSTON SCIENTIFIC CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.